Dr. James McCloskey
Claim this profileHackensack University Medical Center
Studies Leukemia
Studies Myeloid Leukemia
8 reported clinical trials
13 drugs studied
Area of expertise
1Leukemia
Philadelphia chromosome positive
BCR-ABL1 positive
Stage II
2Myeloid Leukemia
Stage II
Stage I
Affiliated Hospitals
Clinical Trials James McCloskey is currently running
CPX-351
for Acute Myeloid Leukemia
This is a phase IB/II study with a 3+3 dose de-escalation study design. Patients will continue maintenance treatment with CPX-351 for 6 cycles on D1 and D3, as long as patient remains in CR. The dose de-escalation will be one dose given on D1 only, every 28 days pending toxicity. The maximum tolerated dose will be used for the phase II expansion portion of the study.
Recruiting1 award Phase 1 & 2
NK Cell Therapy
for Acute Myeloid Leukemia
This study will find the maximum tolerated dose or the maximum planned dose of CYNK-001 which contains natural killer (NK) cells derived from human placental CD34+ cells and culture-expanded. CYNK-001 cells will be given after lymphodepleting chemotherapy. The safety of this treatment will be evaluated, and researchers want to learn if NK cells will help in treating acute myeloid leukemia.
Recruiting1 award Phase 1
More about James McCloskey
Clinical Trial Related8 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments James McCloskey has experience with
- Placebo
- Ponatinib
- Imatinib
- MBG453
- Azacitidine
- Vodobatinib (K0706)
Breakdown of trials James McCloskey has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Primary Myelofibrosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James McCloskey specialize in?
James McCloskey focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved Philadelphia chromosome positive patients, or patients who are BCR-ABL1 positive.
Is James McCloskey currently recruiting for clinical trials?
Yes, James McCloskey is currently recruiting for 2 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that James McCloskey has studied deeply?
Yes, James McCloskey has studied treatments such as Placebo, Ponatinib, Imatinib.
What is the best way to schedule an appointment with James McCloskey?
Apply for one of the trials that James McCloskey is conducting.
What is the office address of James McCloskey?
The office of James McCloskey is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.